Clinical Trials Browser

Interventional × Breast Neoplasms × Dexmedetomidine × Clear all

NCT05439005 2026-01-30

OFOBA

Phase 3 Recruiting

Breast Neoplasms

NCT05146778 2025-11-21

RELIEF

Phase NA Recruiting

Breast Neoplasms, Pain, Postoperative, Chronic Pain

NCT05732064 2025-07-31

Dexmedetomidine-esketamine Combined Nasal Administration and Perioperative Sleep Quality

Phase 4 Completed

Breast Neoplasms, Sleep Initiation and Maintenance Disorders

NCT06947330 2025-04-27

FMASUMD66/2025

Phase 3 Recruiting

Breast Neoplasms

NCT06252662 2024-11-19

Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies

Phase 4 Recruiting

Breast Neoplasms, Pain, Postoperative

NCT06354478 2024-04-09

IV Dexmedetomidine vs Oral Gabapentin and Their Combination for Postoperative Analgesia in Cancer Patients Undergoing Modified Radical Mastectomy

Phase NA Completed

Breast Neoplasms, Pain, Postoperative, Acute Pain

NCT06300099 2024-03-12

Dexamethasone Versus Dexmedetomidine as Adjuncts to Serratus Anterior Plane Block

Phase 4 Unknown

Breast Neoplasms

NCT03109990 2022-11-10

A Pilot Study to Evaluate the Impact of Dexmedetomidine on Breast Cancer Recurrence After Surgery

Phase NA Completed

Breast Neoplasms

NCT04029467 2021-02-23

Effect of Dexmedetomidine on the Duration of Pain Control in ESP Block for Breast Surgery

Phase 4 Unknown

Breast Neoplasms, Pain, Pain, Postoperative

NCT03456661 2019-09-20

Comparison Between Levobupivacaine and Levobupivacaine With Dexmedetomidine in Ultrasound Guided Pectoral Nerve Block

Phase 4 Terminated

Breast Neoplasms

NCT03108937 2017-10-10

Effects of Dexmedetomidine on Breast Cancer Cell Function in Vitro

Phase NA Completed

Breast Neoplasms

NCT01548209 2015-02-02

Effects of a Dexmedetomidine on Quality of Recovery 40 and Postoperative Nausea and Vomiting in Breast Cancer Surgery

Phase NA Completed

Breast Neoplasms